Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,188
Closed -$2.07M 1009
2025
Q3
$2.07M Sell
25,188
-4,472
-15% -$322K 0.01% 374
2025
Q2
$1.95M Buy
+29,660
New +$1.85M 0.01% 372
2024
Q4
Sell
-40,988
Closed -$3.42M 992
2024
Q3
$3.42M Sell
40,988
-734
-2% -$48.9K 0.02% 281
2024
Q2
$2.3M Buy
41,722
+4,487
+12% +$244K 0.02% 313
2024
Q1
$2.59M Buy
37,235
+4,833
+15% +$306K 0.02% 311
2023
Q4
$1.8M Sell
32,402
-3,308
-9% -$149K 0.01% 350
2023
Q3
$1.28M Buy
35,710
+432
+1% +$14.9K 0.01% 398
2023
Q2
$1.12M Buy
35,278
+6,387
+22% +$244K 0.01% 464
2023
Q1
$890K Sell
28,891
-835
-3% -$25.3K 0.01% 494
2022
Q4
$921K Buy
+29,726
New +$682K 0.01% 494

Other funds holding ACLX

ALPS Advisors's ACLX Position: Q4 2025 in Review

ALPS Advisors sold out of Arcellx (ACLX) in Q4 2025, closing a stake of 25,188 shares — an estimated $2.07M sold.

ALPS Advisors first reported a position in ACLX in Q4 2022 and held it in 10 quarters. The position peaked at $3.42M in Q3 2024. 218 funds tracked by Wall St. Rank hold ACLX as of Q4 2025.

  • ALPS Advisors reported no remaining Arcellx position as of Q4 2025 after selling out during the quarter.
  • ALPS Advisors sold 25,188 Arcellx shares in Q4 2025, an estimated $2.07M.
  • ALPS Advisors first reported a position in Arcellx in Q4 2022 and held it in 10 quarters.
  • ALPS Advisors's Arcellx position peaked at $3.42M in Q3 2024.
  • 218 funds tracked by Wall St. Rank held Arcellx as of Q4 2025.

Based on ALPS Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.